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Mouse cells infected by the Friend,  Moloney, or Rauscher leukemia  viruses  (LV) 1 
express  on  their  surfaces  a  cross-reactive  antigen,  FMR,  which  can  be  detected 
serologically  (1).  This  antigen  is  absent  from  cells  infected  by  Gross  LV,  a  virus 
derived  from leukemic AKR  mice and showing genetic and  structural  relationships 
with  Friend,  Moloney,  and  Rauscher  LV.  Gross  LV-infected  cells  express  a  Gross 
virus-associated cell-surface antigen  (GCSA) which can be detected serologically and 
which does not cross-react with FMR antigen  (2). 
Studies of the cytolytic T  lymphocyte (CTL)  response in mice to syngeneic tumor 
cells induced by murine RNA LV have centered around LV of the FMR class. CTL 
sensitized  against  syngeneic tumor cells expressing the  FMR  antigen  are capable of 
killing any syngeneic FMR-positive tumor cell; the same CTL, however, spare FMR- 
negative tumor cells induced by Gross LV, by chemical carcinogens, or by x rays (3- 
5). This pattern of specificity is parallel  to that seen in serological studies, suggesting 
that the viral specificity of CTL involves the same antigen recognized by antibodies. 
However,  the  specificity  of CTL  generated  in  the  mouse  in  response  to  syngeneic 
Gross LV-induced tumor cells has not been defined. 
CTL specific for FMR-positive  tumor cells show a  second specificity not detected 
in serological studies.  This second specificity is directed against antigens encoded by 
the  H-2K  and/or  H-2D  genes  of the  major  histocompatibility  complex.  Previous 
studies  showed  that  FMR-specific  CTL  of the  H-2 b  haplotype  were  effective  only 
against tumor cells bearing the H-2D b antigen; CTL of the H-2 a or H-2 k haplotypes, 
however,  appeared  to be restricted  to tumor cells  bearing  syngeneic H-2K  antigens 
(6-8). 
This communication concerns studies of the CTL response to syngeneic Gross LV- 
induced  tumor cells.  An earlier  report  by Meruelo  et  al.  (9)  indicated  that  a  CTL 
response could be generated in mice against cells of a  spontaneous lymphoma of the 
AKR  strain,  from which  the  Gross  LV was originally derived.  Our results  indicate 
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that  a  CTL  response specific for syngeneic Gross LV-induced  tumor cells could  be 
elicited in  mice of strains congenic  to BALB/c  but  differing at H-2.  The cytotoxic 
effector cells generated in vivo were diverse; however, effector-cell generation in mixed 
leukocyte-tumor  cell  cultures  (MLTC)  allowed  us  to  selectively  study  the  CTL 
response. These CTL were efficient in destroying syngeneic Gross LV-indueed tumor 
cells,  but  not  syngeneic  FMR-positive  tumor  cells.  Furthermore,  their  pattern  of 
specificity for  H-2K  or H-2D  antigens  was  somewhat  different  from  that  seen  in 
parallel studies of FMR-specifie CTL. 
Materials  and  Methods 
Mice.  All mice were bred in our colonies at the Albert Einstein College of Medicine, Bronx, 
b  N.  Y. The inbred strains used included C57BL/6  (B6, H-2  )  and the series of H-2-congenic 
strains, BALB/c (H-2d), BALB.B (H-2b), BALB.K (H-2*), BALB.G (H-2g), and BALB.5R (H- 
2~5). 
Tumors.  Leukemia cells induced by Rauscher LV, Friend LV, Moloney LV, Gross LV, or 
chemical carcinogens were used. RBL-5 lymphoma cells (10), induced by Rauscher LV; MBL- 
2 lymphoma cells (10),  induced by Moloney LV; EgG2 leukemia cells (2),  induced bYbGross 
LV; and EL4 leukemia cells (11), induced by benzpyrene, were derived in B6 mice ~q-2  ) and 
were maintained by serial passage in vivo. Friend LV-induced HFL/b cells (H-2),  derived 
from BALB.B mice (12), were maintained as stationary suspension cultures in Eagle's minimal 
essential medium (MEM) supplemented with 20% fetal bovine serum (FBS). Continuous cell 
cultures of tumors induced by Gross LV were derived in an analogous manner (12): newborn 
mice were  injected  i.p.  with  0.1  ml  of an  acellular preparation of Gross  LV derived from 
leukemic BALB/c mice. 2-3 mo later, the mice developed leukemia, and their enlarged spleens 
were minced into small fragments and injected s.c.  into normal syngeneic adult mice. Single- 
cell suspensions were prepared from the resulting solid tumors and set in culture at various cell 
concentrations in MEM supplemented with 20% FBS. Continuous cell lines obtained in this 
manner  from  various strains of mice were:  B.GV cells (H-2 b, BALB,B), C.GV cells (H-2 d, 
BALB/c),  K.GV  cells  (H-2 k,  BALB.K),  G.GV cells  (H-2 g,  BALB.G),  5R.GV  cells  (H-2 i5, 
BALB.5R), and B/CF1.GV cells (H-2 b/a, [BALB.B  ×  BALB/c]F~). Serological analysis (per- 
formed by Dr. E. Stockert of Sloan-Kettering Memorial Institute, New York) using B6 anti- 
K36  AKR leukemia serum  showed  that  those  lines tested  (B.GV,  C.GV,  and  K.GV)  were 
GCSA-positive. 
Immunization Procedures.  Adult mice were given 107 x-irradiated (5,000 rad) syngeneic tumor 
cells i.p. and allowed to rest for 20-40 d. These primed mice were (a) given a secondary s.c. or 
i.p. inoculum of 106 untreated tumor cells, or (b) used as a source of leukocytes in MLTC. 
Leukocyte Suspensions.  Peritoneal exudate cells (PEC) were recovered by flushing the perito- 
neal cavity of each mouse twice with 5 ml MEM-5% FBS. Cell suspensions were prepared from 
the spleen, mesenteric lymph node  (MLN), or the peripheral lymph nodes  (PLN)  by gentle 
disruption  in  a  TenBroeck  cell  homogenizer  (Fisher Scientific Co.,  Pittsburgh,  Pa.).  The 
leukocytes were suspended in  10 ml MEM-5% FBS, pelleted by centrifugation at 600 g for 5 
rain, and resuspended in  10 ml MEM-5% FBS. Debris was removed by sedimentation at unit 
gravity for 15 min. Each cell suspension was collected, pelleted at 600 g for 5 min, re'suspended 
in MEM-5% FBS, and counted for viability. 
Lymphocyte Cultures.  LV-specific CTL were generated in MLTC from spleen cells of primed 
mice. Syngeneie MLTC were established in 20 ml RPMI- 1640 medium (Grand Island Biological 
Co., Grand Island, N. Y.) supplemented with 5% FBS and 5  ×  10 -s M  2-mercaptoethanol, by 
mixing 2.5  ×  10  7 spleen cells with 1 ×  10  e x-irradiated (5,000  rad) syngeneic tumor cells. The 
cells were harvested after 6 d in culture, washed, and counted for viability. 
51Chromium Release Cytotoxicity Assay.  Cell-mediated anti-tumor eytolytic activity was detected 
using a modification of the method of Brunner et al. (13). Varying numbers of viable lymphoid 
cells were mixed with 104 51Cr-labeled tumor cells in a final vol of 0.2 ml MEM-20% FBS. After 
6 or 18 h  incubation at 37°C,  the supernates were harvested and measured for radioactivity. 
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according to the following formula: 
ER  -  SR 
X  100, 
MR -  SR 
where ER was the observed experimental 51Cr release; SR, the spontaneous release detected by 
incubating  the  target  cells in  culture  medium  alone;  and  MR,  the  maximum  amount  of 
radioactivity released from the target cells after incubation in 0.2 ml 1 N HCI for the duration 
of the assay. The spontaneous release (SR) values of the various tumor target cells used varied 
between 4 and  10% of the total incorporated label for 6-h incubation periods, and between 10 
and 25% for 18-h incubation periods. 
Cold Target Cell Inhibition Assay.  CTL specificity for target antigens was analyzed by adding 
unlabeled competitor target cells to the 51Cr release cytotoxicity assay (4). Varying numbers of 
cold target cells were mixed with  104 51Cr-labeled target cells in 0.1  ml culture medium; 5  × 
105 effector lymphocytes were then added in 0.1 ml to each well, and the plates were incubated 
for 6 h  at 37°C. The percentage of inhibition of cytotoxicity was calculated according to the 
formula: 
Cont. -  Exp. 
x  100, 
Cont. 
where Cont.  was the specific cytotoxic activity detected in positive control wells containing 
effector  lymphocytes  and  51Cr-labeled  target  cells  only;  and  Exp.  was  the  experimental 
cytotoxicity values obtained from wells containing cold target cells, 51Cr-labeled target cells, 
and effector lymphocytes. 
Macrophage Depletion with Carbonyl Iron.  Macrophages and other phagocytic and/or adherent 
cells were removed from leukocyte suspensions by incubation of 3 ×  10  viable leukocytes with 
40 mg carbonyl iron (Technicon Instruments Corp., Tarrytown, N. Y.)  in  10 ml MEM-20% 
FBS at 37°C for 30 min with continuous shaking, followed by passage over a magnet (14). 
Elimination of T Cells by AKR Anti-Thy  1.2 Serum.  Aliquots of 2  ×  107 viable lymphoid cells 
were  suspended  in  1 ml  MEM  containing AKR  anti-Thy-l.2 serum  (10 -1  final  dilution), 
prepared by five successive immunizations of AKR mice with normal C3H thymus cells (15). 
After 30  rain of incubation at  37°C,  2  ml  MEM  containing  10%  rabbit serum  (previously 
absorbed on agarose) was added to the cells as a source of complement, and the mixture was 
further incubated for 45 min at 37°C. After two washes in 10 ml MEM-5% FBS, the remaining 
cells were counted for viability and tested for cytotoxicity. Previous assays have indicated that 
this procedure results in the complete depletion of all T cells identifiable by immunofluorescent 
techniques (14). 
Results 
Generation In  Vivo of Cytotoxic  Cells  in Response  to Gross L V-induced  Tumors.  Tumors 
were  induced  by Gross  LV  in  six  strains  of mice  congenic  to  BALB/c  at  the  H-2 
region of chromosome  17 and expressing the homozygous haplotypes H-2 b, H-2 d, H- 
2 k, H-2 g, or H-2  ~, or the heterozygous haplotype H-2 b/d. Each tumor was adapted to 
growth in vitro as a  continuous line, and initial experiments showed that all cultures 
retained their tumorigenic potential in vivo when inoculated s.c. into syngeneic hosts 
(100%  mortality at <_ 3 wk after doses of 10~-106 cells). However, at least 50% of the 
inoculated mice rejected their syngeneic tumor in each case when  given  104 or fewer 
tumor  cells. This  indicated  the  existence  of an  immune  response  to  these  tumors, 
presumably triggered by a  Gross LV-induced tumor antigen. In this context, serolog- 
ical typing indicated that the cells of each line tested were GCSA-positive. 
A  series  of experiments  was  performed  to  examine  the  cell-mediated  cytotoxic 
response  to  these  Gross  LV-induced  tumors.  Initial trials  revealed  the  presence  of 
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TABLE  I 
Time-Course of the Secondary Cytotoxic Response of BALB.B Mice to B.GV Tumor Cells 
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Effector cells 
Percentage of specific blCr release 
Day 1  Day 3  Day 5  Day 8 
100:1  30:1  10:1  100:1  30:1  10:1  100:1  30:1  10:1  100:1  30:1  10:1 
% 
MLN  0  0  0  10  9  6  0  0  0  0  0  0 
PLN  0  0  0  3  2  0  0  0  0  4  3  0 
Spleen  0  0  0  5  6  4  14  5  5  18  6  5 
Spleen +  NMS +  C*  ....  19  7  5  --  --  -- 
Spleen  +  anti-Thy  ....  5  4  3  --  --  -- 
1.2 +  C* 
PEC  0  0  0  73  56  26  52  20  8  27  14  4 
PEC +  NMS +  C*  ......  55  18  4  --  --  -- 
PEC +  anti-Thy 1.2  ......  14  4  0  --  --  -- 
+  C* 
PEC +  Fe~  ....  25  12  0  --  --  -- 
BALB.B mice were immunized with 107 x-irradiated B.GV cells i.p. on day -27, and subsequently given 
a boost of 10  n untreated B.GV cells on day 0. Leukocytes  were extracted from various lymphoid organs 
1, 3, 5, and 8 d after the boost and assayed  for lysis of StCr-labeled  B.GV cells in an  18-h cytotoxicity 
assay at three different lymphocyte to target-cell ratios. 
* 2  ×  107 leukocytes  were incubated with normal mouse serum (NMS) or AKR anti-Thy 1.2 serum and 
rabbit complement (C), washed twice, and assayed  for cytolytic activity on B.GV cells. 
3 X  107 PEC were incubated with carbonyl iron (Fe) for 30 rain at 37°C and then passed over a magnet 
to remove macrophages and other phagocytes. 
s.c.,  with  syngeneic  B.GV  cells.  Table  I  shows  that  cytolytic cells capable  of lysing 
B.GV cells in a  long-term  (18  h)  51Cr-release assay could  be recovered among  MLN 
cells, spleen cells, and PEC. PLN  cells isolated from the inguinal lymph nodes did n6t 
contain cytolytic cells. Table  I  also shows that  PEC  contained  the highest  number  of 
cytolytic cells, and that the peak of activity occurred 3-5 d  after the secondary boost. 
Other experiments  indicated that cytotoxic activity dropped  to negligible levels after 
day  10 in all tissues. 
Attempts  to  identify  these cytotoxic cells indicated  that  they  were constituted  in 
part  by  thymus-derived  (i.e.,  T)  cells,  because  incubation  with  anti-Thy-l.2  serum 
and rabbit complement  induced a  significant but incomplete abrogation of their lytic 
activity  (Table  I,  day  5).  Moreover,  PEC  cytotoxicity was  also mediated  by  macro- 
phages  and/or  other phagocytic  cells,  because  cytolysis decreased  after depletion  of 
phagocytic and adherent  cells with carbonyl  iron  (Table I, day 5). 
Further  experiments  showed  a  general  lack  of specificity  among  cytolytic  PEC 
generated  in  vivo.  Table  II  shows  that  the  lytic  activity of these  cells was  specific 
neither  for 1-1-2 nor  for viral antigens.  Effector cells from  BALB.B  (H-2~,  BALB/c 
(H-2d), and  BALB.K  (H-2~  mice lysed  tumor  cells induced  by  both  Gross  LV  and 
Friend  LV,  irrespective  of their  H-2  haplotype.  These  results  indicated  that  Gross 
LV-induced  tumor  cells generated  a  cytotoxic response  in  vivo which  was  heteroge- 
neous with respect to the nature  of the killer cells and  which lacked specificity. 
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TABLE II 
Lack of Specificity of Cytotoxic PEC after Secondary In Vivo Immunization 
Percentage of specific 51Cr release 
Target cells  BALB.B anti-B.GV  BALB/c anti-C.GV  BALB.K anti-K.GV 
100:1  30:1  10:1  100:1  30:1  10:1  100:1  30:1  10:1 
% 
Gross LV-induced 
B.GV (H-2  b)  28  10  l  24  6  5  12  3  0 
C.GV (H-2  d)  22  4  0  50  19  2  6  3  3 
K.GV (H-2k)  60  28  tl  51  22  14  36  14  2 
Friend LV-induced 
HFL/b (14-2  b)  25  7  2  48  12  1  i5  l  2 
HFL]d (H-2  a)  24  8  3  45  18  3  24  11  l 
HFL/k (tl-2  k)  30  6  2  51  13  6  23  5  0 
BALB.B, BALB/c, and BALB.K mice received 107 x-irradiated  B.GV, C.GV, or K.GV tumor cells, 
respectively, on day -36 and 10  e untreated  tumor cells on day 0. On day 3 after the secondary boost, 
PEC from each group of mice were collected and assayed for cytotoxicity on a panel of SlCr-labeled 
tumor cells in an 18-h cytotoxicity assay at various lymphocyte to target-cell ratios, as indicated. 
which allowed the exclusive study of the CTL response elicited by immunization with 
Gross  LV-induced  tumor  cells.  This  system  involved  the  generation  of CTL  in 
syngeneic MLTC. Table III shows that cytotoxic cells, detectable in a 6-h 51Cr-release 
cytotoxicity  assay,  could  be  generated  in  MLTC  by  stimulating  BALB.B  spleen 
lymphocytes with B.GV cells. Spleens from either normal BALB.B mice (i.e., primary 
MLTC)  or BALB.B mice primed  with  B.GV cells  30  d  previously  (i.e.,  secondary 
MLTC) could be used as sources of CTL precursor cells. The data in Table III show 
that secondary MLTC was 30 times more efficient than primary MLTC in generating 
CTL, because 3  X  104 secondary MLTC  cells yielded cytotoxicity comparable to  1 
X  10  e primary MLTC  cells (i.e.,  11 and  18% specific SlCr release, respectively). 
Subsequent studies showed that cytolytic cells could also be generated in syngeneic 
secondary MLTC  with  spleen  cells  from BALB/c and  BALB.K mice primed  with 
syngeneic Gross LV-induced tumor cells (Table IV). Furthermore, each cytotoxic cell 
population was comprised essentially of T  lymphocytes, because their effect could be 
eliminated by incubation with anti-Thy-1.2 serum in the presence but not the absence 
of complement  (Table IV). Other experiments  (data not shown)  also indicated  that 
macrophage  depletion  slightly  increased,  and  did  not  inhibit,  the  cytotoxicity me- 
diated  by  MLTC  cells from  BALB.B,  BALB/c,  or BALB.K mice.  It  thus  became 
apparent that the cytolytic effector cells generated in oursyngeneic secondary MLTC 
system and detected in 6-h cytotoxicity assays were of thymic origin. 
Viral Specificity of CTL Generated in MLTC.  A series of experiments was designed to 
study the capacity of CTL generated in MLTC  to recognize diverse tumor antigens. 
CTL were generated in syngeneic secondary MLTC against H-2 b tumor cells induced 
by Rauscher  LV  (i.e.,  B6 anti-RBL-5),  Friend  LV  (i.e.,  BALB.B anti-HFL/b),  and 
Gross LV (i.e., BALB.B anti-B.GV).  Each CTL population was assayed on a panel of 
SaCr-labeled H-2 b tumor target cells which expressed FMR antigen (HFL/b, MBL-2, 
and  RBL-5 cells)  or GCSA  (B.GV  cells).  Table  V  shows  that  B6 anti-RBL-5  and 
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TABLE III 
Lysis of~tCr-labeled B.GV Cells by BALB.B Lymphoqytes Harvested  from Primwy and Secondary 
Syngeneic ML TC 
Source of killer cells 
Percentage of specific 5~Cr release 
100:I  30:1  I0:1  3:1  I:1 
% 
Primary MLTC  18  7  3  0  0 
Secondary MLTC  88  61  47  11  5 
MLTC were established with l0  s x-irradiated B.GV cells and 25  X  l0  s respondin~ lymphocytes from 
normal BALB.B mice (i.e., primary MLTC) or from BALB.B mice primed with 10  x-irradiated B.GV 
cells 30 d earlier (i.e., secondary MLTC). After 6 d incubation, the lymphocytes  recovered from MLTC 
were assayed for lytic activity against B.GV cells at various lymphocyte  to target-cell ratios in a 6-h StCr- 
release assay. 
from those expressing GCSA, because FMR-positive cells were lysed at least I0 times 
more efficiently than GCSA-positive cells. Conversely, BALB.B anti-B.GV CTL killed 
B.GV target  cells  at  least  30  times  more efficiently than  any of the  FMR-positive 
target  cells.  Consequently,  CTL  generated  in  syngeneic  secondary  MLTC  were 
capable of selectively recognizing tumor target cells positive for FMR antigen or for 
GCSA. This conclusion was confirmed by other experiments, as shown in Fig.  I. It 
became apparent (Fig.  1 A) that BALB.B CTL generated against B.GV tumor cells in 
MLTC were capable of destroying EdG2 tumor cells (H-2 b, induced by Gross LV in 
B6 mice), as well as B.GV tumor cells,  but  not  EL4 tumor cells  (H-2 ~, chemically 
induced  in  B6  mice).  In addition,  BALB.B CTL generated  against  HFL/b  cells in 
MLTC  (Fig.  1 B)  killed  FMR-positive  HFL/b  and  RBL-5  target  cells,  but  were 
incapable of destroying E~G2 cells,  B.GV cells, or EL-4 cells.  It should be stressed, 
however, that the observed viral specificities of CTL were not absolute, because low 
levels of cross-reactivity could sometimes be observed (Table V  and Fig.  1). 
Restriction by H-2 Antigens of Gross L V-specific CTL Actwity.  The H-2 transplantation 
antigens  of the  target cell  had  a  restrictive effect on  its  recognition  by Gross LV- 
specific CTL. The two parallel assays summarized in Fig. 2 concerned cold target cell 
competition of the lyric activity of Gross LV-specific CTL from BALB.B (H-2~ and 
BALB/c (H-2 d) mice. A constant number of 104 51Cr-labeled B/CF1.GV tumor cells 
(H-2b/H-2 a heterozygous)  were  mixed  with  increasing  numbers  of unlabeled  (i.e., 
cold) Gross LV-induced tumor cells of different 14-2 haplotypes, and incubated with 
5  ×  105  MLTC  cells.  Lysis  mediated  by  CTL  from  BALB.B  mice  (H-2 b)  was 
efficiently inhibited by cold 14-2  bid and 1-1-2  b Gross LV-induced tumor cells, and not 
by H-2 a tumor cells (Fig.  2 A). On the other hand, CTL from BALB/c mice (H-2 a) 
were inhibited  in  their lytic activity by H-2 b/a and H-2 a Gross LV-induced  tumor 
cells, but not by H-2 b tumor cells (Fig. 2 B). When cold H-2* Gross LV-induced tumor 
cells were assayed with either set of CTL, a  small degree of inhibition  was observed 
with both H-2 b and H-2 a CTL at high doses of cold H-2 k tumor cells.  However, at 
least  10 times more cold H-2 k tumor cells were required  to reach the same degree of 
inhibition as observed with cold H-2-identical tumor ceils. These data thus indicate 
that  H-2 antigens  played a  role in  the recognition of the target  tumor antigens  by 
Gross LV-specific CTL. 
Attempts  were  made  to  extend  these  data  by  measuring  the  degree  of CTL- 
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TAnLE  IV 
Identification of Gross L V-specific Effector Cells From ML TC 
Percentage of specific 51Cr release 
Anti-Thy 1.2 +  Anti-Thy 1.2 +  C  Effector cells  Target cells  No treatment  MEM 
30:1  10:1  3:1  1:1  30:1  10:1  3:1  1:1  30:1  10:1  3:1  1:1 
% 
BALB.B anti-B.GV  B.GV  64  48  38  20  62  51  44  18  6  4  1  0 
BALB/c anti-C.GV  B/CF~.GV  15  5  3  1  21  9  4  2  4  1  0  0 
G.GV  30  9  2  4  42  12  4  2  0  0  0  0 
BALB.K anti-K.GV  K.GV  21  6  2  1  20  10  6  2  7  6  4  0 
Gross LV-specific effector cells were generated in s~ngeneic secondary MLTC, harvested on day 6 after 
culture initiation, and counted. Aliquots of 2 ×  10  viable lymphocytes were incubated with AKR anti- 
Thy-l.2 serum in the absence or presence of rabbit complement, washed twice, recounted, and assayed 
for cytotoxicity at various lymphocyte to target-cell ratios in a 6-h 5~Cr-release  assay. 
bearing H-2-recombinant haplotypes. Table VI summarizes the results obtained with 
tumor cells of the H-2 s  haplotype (H-2KdD n, G.GV  cells) and H-2 i5 haplotype  (H- 
2KnD a, 5R.GV cells). BALB.B anti-B.GV CTL (H-2KbD b) were efficient killers of all 
Gross LV-induced target cells expressing either H-2K b or H-2D b antigens, or both. 
There  was  no  absolute  requirement  for  the  expression  of either  H-2K b or H-2D b 
antigens, because the single expression of H-2K b or H-2D b antigen was sufficient for 
lysis. In agreement with results shown in Fig. 2, Gross LV-induced C.GV tumor cells 
from BALB/c mice (H-2KaD a) were not killed by BALB.B CTL;  K.GV tumor cells 
from  BALB.K mice  (H-2KhD k)  were  lysed only  to  a  minimal extent  (30  times less 
efficiently than B.GV cells from BALB.B mice). 
Analogous  assays  with  Gross  LV-specific  CTL  from  BALB/c  mice  (H-2KaD a) 
revealed  a  different  pattern  of restriction  by 11-2: as  shown  in  Table  VI,  H-2K a 
antigens seemed to be necessary and sufficient for recognition of Gross LV-induced 
tumor antigens. The presence of H-2D a antigens  (in the absence of H-2K a)  was not 
sufficient, because  5R.GV  tumor cells (H-2KbD a)  were poorly lysed. BALB/c CTL 
were incapable of killing B.GV tumor cells (H-2KbDn),  and killed K.GV tumor cells 
(H-2KkD ~)  to  a  minimal extent.  Furthermore,  although  BALB/c  anti-C.GV  CTL 
efficiently lysed B/CF1.GV hybrid tumor cells (H-2b/a), they were incapable of lysing 
C.GV cells from BALB/c mice. The reason for this inability to lyse C.GV cells is not 
understood,  because  C.GV  cells induced  the  generation  of H-2d-restricted  CTL  in 
MLTC,  inhibited the lysis of B/CFx.GV tumor  target ceils by BALB/c  anti-C.GV 
CTL  (Fig. 2 B), and were susceptible to lysis by BALB.B (H-2 b) anti-H-2 a CTL  (not 
shown).  This  peculiar resistance to  lysis manifested by C.GV  ceils is not  a  general 
characteristic of Gross LV-induced tumor cells in BALB/c  mice:  we  have  recently 
established two new BALB/c-GV lines which proved to be susceptible to Gross LV- 
specific  CTL  from  BALB/c  mice  (data  not  shown),  when  assayed  shortly  after 
establishment as continuous cell lines. 
It was  difficult to  generate Gross LV-specific CTL  in  MLTC  from  BALB.K  (H- 
2KkD ~) immune spleen ceils. As shown in Table IV and VI, the cytotoxic activity was 
low, with  values rarely surpassing 25%  specific 51Cr release at  100:1  lymphocyte to 
target cell ratios. These low levels of cytolytic activity, however, were mediated by T FERNANDO PLATA AND FRANK LILLY 
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Target cells 
Percentage of specific ~lCr release 
B6 anti-RBL-5  BALB.B anti-HFL/b  BALB.B anti-B.GV 
100:1  30:l  10:1  3:1  I:1  100:1  30:1  10:1  3:1  1:I  100:1  30:1  10:1  3:1  l:l 
% 
HFL/b (Friend LV)  32  20  8  4  0  23  18  7  2  0  .5  1  0  0  0 
MBL-2 (Moloney LV')  41  26  12  I  0  51  27  20  8  5  12  2  0  0  0 
RBL-5 (Rauseher LV)  56  35  10  6  0  .58  37  30  14  5  9  6  2  0  0 
B.GV (Gro~s  LV)  I 1  9  5  0  0  I  2  0  0  0  63  47  19  12  4 
Lympbocytes were harvested after 6 d  of incubation  in MLTC, counted, and  tested  for cytotoxicity against  a  panel  of//-2 b 5tCr-labeled 
target cells at the indicated lymphocyte to target-cell  ratios in a  6-b assay. 
cells (Table IV) and were restricted to BALB.K Gross LV-induced tumor cells (Table 
VI). This finding was in accordance with the observation that H-2 k mice are highly 
susceptible  to leukemia induction  by Gross LV, as compared with 1-1-2  b and H-2 a 
mice (16). 
Discussion 
These data indicate the existence of a  heterogeneous and dynamic cell-mediated 
immune response to Gross LV-induced tumors. Earlier studies  (16)  had revealed an 
H-2-1inked immune resistance to leukemia induction in neonates by Gross LV, such 
that 11-2 b mice proved to be resistant to Gross LV, H-2 h mice were highly susceptible, 
and  H-2 d  mice  were  intermediate.  Further  analyses showed  that  susceptibility or 
resistance to Gross LV was governed in part by a single immune response gene, Rgv- 
1, mapped to the K or I region of H-2 (17). 
The immune resistance to Gross LV-induced leukemia is probably mediated by a 
variety of active cells, including T  and non-T cells. When we studied the secondary 
response in vivo of BALB.B mice to the syngeneic Gross LV-induced tumor B.GV, we 
found  evidence  for  the  existence of cytotoxic T  cells  and  phagocytic non-T  cells 
(probably macrophages)  among PEC.  These cells were particularly active between 
days 3 and 5 after a secondary immunization with B.GV cells; however, they did not 
show obvious 11-2 or tumor specificities in an in vitro cytotoxicity assay, probably a 
result of the presence of nonspecific cytotoxic macrophages. Gomard and colleagues 
(18) previously reported the existence of  similar cytotoxic macrophages in preleukemic 
AKR mice, indicating that Gross LV (endogenous in AKR mice) might be particularly 
effective in activating macrophages. 
Our preliminary aim, however, was to study the specificity of the CTL subpopu- 
lation  present  among  the  cytotoxic cells elicited  in  response  to Gross  LV-induced 
tumors. Previous reports had indicated that Gross LV-specific CTL could be generated 
in rats (19, 20). Consequently, it was particularly interesting to consider murine Gross 
LV-immune CTL with respect to their tumor specificity and to their specificity for 
particular H-2 antigens, and to compare them with the specificities of CTL immune 
to FMR-positive tumor cells. For this purpose we resorted to the generation of tumor- 
specific CTL in vitro. CTL generated in syngeneic MLTC could readily be detected 
in a 51Cr-release cytotoxicity assay and possessed a  high degree of specificity for the 
immunizing LV-induced tumor antigens. 1182  VIRAL AND H-2 SPECIFICITY OF CYTOLYTIC T  LYMPHOCYTES 
A  B 
~  8o 
60 
7,  4O- 
u 
20- 
11  3:;  /0:1  30:;  901  ;I  3:1  10:1  30:!  90:; 
LYMPHOCYTE TO TARGET-CELL RATIO 
FiG.  1.  Viral  specificity  of BALB.B CTL. Gross LV-specific BALB.B anti-B.OV CTL (panel A) 
and Friend LV-specific  BALB.B anti-HFL/b CTL (panel B) were generated in secondary MLTC 
and tested for specificity in a 6-h cytotoxicity assay using the following SlCr-labeled target cells: 
Gross LV-induced B.GV (O) and EdG2 (0) cells; Rauscher LV-induced RBL-5 (I-I) cells; Friend 
LV-induced HFL/b (I) cells; and chemically-induced EL4 (&) cells. 
Specificity studies showed that Gross LV-immune CTL, although recognizing and 
destroying  syngeneic  Gross  LV-induced  tumor  cells  efficiently,  were  incapable  of 
killing  syngeneic  FMR-positive  tumor  cells.  Syngeneic  leukemia  cells  induced  by 
chemical  carcinogens were  also  spared.  Conversely, CTL generated  in  response to 
syngeneic FMR-positive tumor ceils were very poor effectors against syngeneic Gross 
LV-induced tumor ceils. These patterns of CTL tumor specificity were found to be 
true for mice of the H-2 b haplotype (i.e., BALB.B, Table V) and of the 11-2 a haplotype 
(i.e., BALB/c, data not shown). Mice of  the 1t-2  k haplotype (i.e., BALB.K) consistently 
gave weak but  specific CTL responses to syngeneic Gross LV-induced  tumor cells. 
The magnitude of these CTL responses paralleled the relative resistance to leukemia 
induction  by Gross LV in  11-2 n and  1t-2 a  mice, as opposed  to the  high  degree of 
susceptibility in 1-1-2  k mice, attributed to effects of the Rgv-1 gene. 
The tumor specificity evident among Gross LV-specific CTL was accompanied by 
specificity for H-2  antigens;  i.e.,  H-2  restriction.  Attempts were made  to  map this 
restriction to the H-2K or H-2D locus of 1t-2 b and H-2 a mice by using tumor target 
cells induced  by Gross LV in  BALB.G  (H-2KaD ~)  and  BALB.5R  (H-2KbD a)  1-1-2- 
recombinant mice. Our results indicated  that H-2 b CTL from BALB.B mice recog- 
nized Gross LV-induced tumor antigens in association with H-2 determinants coded 
by  either  H-2K b  or  H-2D b  genes.  However,  1-1-2  a  CTL  from  BALB/c  mice  were 
restricted to recognition of Gross LV-induced tumor antigens in association with H- 
2Ka;  association with  H-2D a  did  not  lead  to significant  killing by CTL.  We were 
unable to map the H-2 restriction of H-2 k Gross LV-specific CTL as a result of their 
low and inconsistent cytolytic activities. 
Our observations on the 1t-2 restriction of Gross LV-specific CTL can be compared 
with those made in other systems of CTL immunity concerning tumors induced by 
Friend and Moloney LV: whereas 11-2 b Gross LV-specific CTL were effective in the 
presence of either H-2K b or H-2D ~, H-2 b Friend  LV-specific (7)  and  Moloney LV- 
specific (8) CTL showed a clear preference for tumor antigens associated with H-2D b, 
and not  1-1-21(  n. H-2 a mice were very poor responders to Friend LV-induced tumor 
ceils (6-8). However, the same mice responded well to Moloney LV-induced antigens FERNANDO  PLATA  AND  FRANK  LILLY  1183 
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Fla.  2.  H-2 specificity ofOross LV-immune CTL revealed by competitive inhibition ofcytotoxicity 
using cold target cells. BALB.B anti-B.GV CTL (H-2 b, panel A) and BALB/c anti-C.GV CTL (H- 
2 a, panel B) were generated in MLTC and tested for cytotoxicity in a 6-h assay on 104 51Cr-labeled 
B/CFI.GV target cells (H-2 b/d) at a ratio of 50 lymphocytes to 1 target cell. The average 51Cr release 
values were 31% for BALB.B anti-B.GV CTL and 33% for BALB/c ant  i-C.GV CTL. The following 
unlabeled Gross LV-induced tumor cells were added at  various doses to inhibit cytotoxicity in a 
selective manner: B/CFt.GV  cells (A, H.2b/d),  K.GV cells (&, H-2k), C.GV cells (O, H-2d), and 
B.GV cells (O, H-2b).  The percentage of specific inhibition of cytotoxicity was calculated for each 
dose of cold tumor cells added, as described in Material and Methods. 
(8), and H-2  a CTL had comparable H-2 specificities in the Moloney LV and Gross 
LV  systems.  In  both  cases  association  of tumor  antigen  with  H-2K a  was  clearly 
preferred over association with H-2D  a (8). Finally, and in contrast to the weakness of 
the Gross LV-specific CTL response in  BALB.K mice, moderate CTL responses to 
Friend LV-induced tumors were observed in H-2 k mice, with tumor antigen being 
preferentially recognized in association with H-2K k (7). 
An intriguing paradox raised during the course of our studies was the resistance of 
C.GV tumor cells to lysis by Gross LV-immune CTL. C.GV cells, induced by Gross 
LV in BALB/c mice, were susceptible to lysis by BALB.B (H-2 n) anti-BALB/c (anti- 
H-2 a) CTL. Moreover, C.GV cells could induce the generation of Gross LV-immune 
CTL in  MLTC,  and  could effectively block the  lysis of H-2 b/a  Gross LV-induced 
tumor cells mediated by Gross LV-immune CTL from BALB/c mice. Furthermore, 
two  new  Gross  LV-induced  tumor  cell  lines  from  BALB/c  mice,  tested  in  early 
passages in culture, were susceptible to attack by BALB/c anti-C.GV CTL, and could 
also induce CTL generation in syngeneic MLTC (data not shown). During the course 
of other studies, we observed similar patterns among cells derived from a Friend LV- 
induced tumor, in the sense that certain clones of the HFL/b tumor cell line were 
more susceptible than others to attack by Friend LV-specific CTL; however, those 
clones which proved to be poor targets to CTL attack were excellent stimulators in 
MLTC. Experiments are currently in progress in our laboratory to determine whether 
these patterns  also apply to Gross LV-induced cell lines  and  to other LV-induced 
tumors. 
The  data  presented  in  this  report  thus  provide  further  evidence  for  the  fine 
specificity of recognition and  activity of cytolytic T  lymphocytes. CTL have been 
shown to recognize minor antigenic changes induced by point mutations in H-2 gene 
structure in various models of immunity (21-23). In other systems involving immunity 
to syngeneic cells transformed by viruses or small synthetic haptens, H-2-restricted 
CTL have been shown  to possess a  high capacity for distinguishing  among minor 1184  VIRAL  AND H-2  SPECIFICITY OF  CYTOLYTIC  T  LYMPHOCYTES 
TABLE VI 
H-2 Specificity of Gross L V-specific CTL Generated  m Syngeneic ML TC 
Percentage of specific  51Cr release 
BALB,B anti-B.GV  BALB/c anti-C.GV  BALB.K anti-K.GV  Target cells 
CTL ( H-2 n)  CTL (1-1-2  a)  CTL ( H-2 k) 
30:1  10:1  3:1  1:1  30:1  10:1  3:1  1:1  100:1  30:1  10:l  3:1 
% 
B.GV (H-2KnD n)  54  44  26  15  5  1  0  0  3  0  0  0 
C.GV (H-2KdD a)  0  0  0  0  2  0  0  1  4  1  0  0 
B/CF1.GV (H-2KbmD bin)  33  20  10  3  48  37  25  7  5  2  2  1 
K.GV (H-2K~D k)  9  2  0  0  11  9  3  3  26  7  3  1 
G.GV (H-2KdD b)  23  16  11  6  53  34  25  21  5  0  0  0 
5R.GV (H-2KbD a)  48  36  24  15  17  1  0  0  0  0  0  0 
Specific cytotoxicity was determined in a 6-h StCr-release  assay at the indicated lymphocyte to target-cell 
ratios. 
antigenic differences. CTL sensitized to syngeneic cells infected with  vesicular sto- 
matitis  virus  (VSV),  for  example,  not  only  could  distinguish  among  target  cells 
infected with different strains of VSV, but also could distinguish among cells infected 
by different temperature sensitive mutants of VSV (24).  Similarly, CTL sensitized to 
syngeneic cells infected with  herpes simplex virus  (HSV)  could distinguish  among 
targets infected with HSV type 1 and HSV type 2 (25), and CTL generated against 
influenza virus were specific for distinct categories of influenza virus hemagglutinin 
(26).  Finally, CTL generated in response to syngeneie lymphocytes coupled to the 
hapten 2,3,6-trinitrophenyl (TNP) destroyed syngeneic target cells coupled to TNP, 
but  not  those cells which were coupled to dinitrophenyl  (27), to other nitrophenyl 
compounds  (28), or to p-azophenylarsonate (29), and  vice versa. Our results are in 
accord with the high degree of virus and H-2 specificity seen in these experiments. 
The serologically established distinction between the FMR and the GCSA categories 
of murine  LV  are  clearly maintained  in  our studies  of the  CTL response  to  LV- 
induced tumors. 
Summary 
Cytolytic T  lymphocytes (CTL) were generated against murine tumors induced by 
Gross, Friend, or Rauscher leukemia virus (LV) in syngeneic mixed leukocyte-tumor 
cell cultures. Analogous to the patterns of specificity observed with antibodies to LV- 
induced  cell  surface  antigens,  CTL  could  be  classified  into  two  major  groups  of 
specificity. Tumor cells induced by Friend, Moloney, or Rauscher virus and positive 
for the FMR antigen were killed by syngeneic CTL immune to any one of these three 
LV; the same CTL, however, were incapable of killing syngeneic tumor cells induced 
by Gross LV.  The converse was  true  for Gross LV-specific CTL:  these CTL were 
specific for syngeneic tumor cells expressing the Gross  virus-associated cell-surface 
antigen (GCSA), and not the FMR antigen. The H-2 specificities of the two groups 
of LV-immune CTL were also compared, because in both cases, CTL were restricted 
in their killing activity to H-2-identical tumor target cells. When CTL from single 
strains of mice were generated against syngeneic FMR- or GCSA-positive tumor cells, 
differences were observed with respect both to the requirement for the expression of FERNANDO  PLATA AND FRANK LILLY  1185 
compatible H-2K or H-2D specificities, and to the intensity of the CTL  response in 
congenic mice of the H-2  b, H-2  a, and H-2  k haplotypes. 
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